BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3822445)

  • 21. Coeliac disease.
    O'Farrelly C; Kelly J; Feighery C; Rees JP; Monaghan H; Tempany E; Weir DG
    Ir Med J; 1985 Oct; 78(10):299. PubMed ID: 4066263
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of anti-reticulin and anti-gliadin antibodies for the diagnosis of celiac disease].
    Humbel R; Seligman R
    Bull Soc Sci Med Grand Duche Luxemb; 1987; 124(1):39-43. PubMed ID: 3311431
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunoglobulin allotypes and the immune response to wheat gliadin in a Finnish population with celiac disease.
    Fedrick JA; Pandey JP; Verkasalo M; Teppo AM; Fudenberg HH
    Exp Clin Immunogenet; 1985; 2(4):185-90. PubMed ID: 3917148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum IgA anti-gliadin antibodies (monomeric versus dimeric) in childhood coeliac disease.
    Mascart-Lemone F; Van Pachterbeek T; Duchateau J; Servais G; Cadranel S; Delacroix D
    Acta Gastroenterol Belg; 1986; 49(4):415-22. PubMed ID: 3577611
    [No Abstract]   [Full Text] [Related]  

  • 25. [Gliadin-induced migration inhibition of peripheral leucocytes by the agarose-plate technique in patients with coeliac disease (author's transl)].
    Douwes FR; Lippmann-Nielsen I; Hanke R
    Dtsch Med Wochenschr; 1977 May; 102(19):721-4. PubMed ID: 858274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
    Agardh D
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular response to alpha-gliadin in untreated coeliac disease.
    O'Farrelly C; Feighery C; Greally JF; Weir DG
    Gut; 1982 Jan; 23(1):83-7. PubMed ID: 7035300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive alterations in vesicular trafficking increase the sensitivity of cells from celiac disease patients to gliadin.
    Lania G; Nanayakkara M; Maglio M; Auricchio R; Porpora M; Conte M; De Matteis MA; Rizzo R; Luini A; Discepolo V; Troncone R; Auricchio S; Barone MV
    Commun Biol; 2019; 2():190. PubMed ID: 31123714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunofluorescent serum gliadin antibody assays in celiac disease.
    Stern M
    J Pediatr; 1984 Feb; 104(2):320-1. PubMed ID: 6363662
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum antibodies to gliadin and other cereal proteins in patients with coeliac disease and dermatitis herpetiformis.
    Kieffer M
    Dan Med Bull; 1985 Oct; 32(5):251-62. PubMed ID: 4053695
    [No Abstract]   [Full Text] [Related]  

  • 31. Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides.
    Bernardo D; Garrote JA; Fernández-Salazar L; Riestra S; Arranz E
    Gut; 2007 Jun; 56(6):889-90. PubMed ID: 17519496
    [No Abstract]   [Full Text] [Related]  

  • 32. Adaptive and innate immune responses in celiac disease.
    Gianfrani C; Auricchio S; Troncone R
    Immunol Lett; 2005 Jul; 99(2):141-5. PubMed ID: 15876458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-gliadin antibodies in childhood coeliac disease.
    Kelly J; O'Farrelly C; Rees JP; Feighery CF; Weir DG
    Lancet; 1985 Sep; 2(8454):558-9. PubMed ID: 2863581
    [No Abstract]   [Full Text] [Related]  

  • 34. [Serological diagnosis of celiac disease: anti-gliadin peptide antibodies and tissue anti-transglutaminase].
    Piaggio MV; Demonte AM; Sihufe G; Garcilazo S; Esper MC; Wagener M; Aleanzi M
    Medicina (B Aires); 1999; 59(6):693-7. PubMed ID: 10752210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The identification of the immunodominant gliadin epitope].
    Sela B
    Harefuah; 2003 Jul; 142(7):554-7, 564. PubMed ID: 12908394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease.
    Lähteenoja H; Mäki M; Viander M; Räihä I; Vilja P; Rantala I; Toivanen A; Syrjänen S
    Am J Gastroenterol; 2000 Oct; 95(10):2880-7. PubMed ID: 11051363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research on the in-vitro toxicity of an enzymatic preparation of gliadin against fibroblasts of celiac and normal patients].
    Rusconi R; Borgonovo M; Porro CB; Roggero P
    Minerva Pediatr; 1978 Jan; 30(1):15-8. PubMed ID: 634244
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-mediated immunity to gliadin within the small-intestinal mucosa in celiac disease.
    Nutr Rev; 1975 Sep; 33(9):267-8. PubMed ID: 1099482
    [No Abstract]   [Full Text] [Related]  

  • 39. Are antigliadin antibodies specific for celiac disease?
    Kumar V; Lerner A; Jain N; Beutner EH
    J Pediatr Gastroenterol Nutr; 1984 Nov; 3(5):815. PubMed ID: 6502385
    [No Abstract]   [Full Text] [Related]  

  • 40. Stimulation of lymphocytes from patients with coeliac disease by subfraction of gluten.
    Lancet; 1976 Sep; 2(7986):629-30. PubMed ID: 61364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.